Stockreport

Abeona Therapeutics: ZEVASKYN Data Key In Gauging Momentum - Why I Hold [Seeking Alpha]

Abeona Therapeutics Inc.  (ABEO) 
Last abeona therapeutics inc. earnings: 3/16 04:20 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.abeonatherapeutics.com
PDF ZEVASKYN, a one-time gene therapy for severe skin disorder, faces execution risks but offers potential market share versus established competitor Vyjuvek. ABEO mainta [Read more]